Selection of the R263K mutation to dolutegravir in cerebrospinal fluid HIV-1 virus in one patient with HIV-associated neurocognitive disorders

AIDS. 2016 Sep 10;30(14):2257-8. doi: 10.1097/QAD.0000000000001194.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anti-Retroviral Agents / therapeutic use*
  • Cerebellar Diseases / cerebrospinal fluid
  • Cerebellar Diseases / diagnosis
  • Cerebellar Diseases / etiology*
  • Drug Resistance, Viral
  • Female
  • HIV Infections / cerebrospinal fluid
  • HIV Infections / complications*
  • HIV Infections / drug therapy
  • HIV Integrase
  • HIV Integrase Inhibitors / adverse effects*
  • HIV-1 / genetics*
  • Heterocyclic Compounds, 3-Ring / adverse effects*
  • Humans
  • Middle Aged
  • Mutation*
  • Neurocognitive Disorders
  • Oxazines
  • Piperazines
  • Pyridones
  • Recurrence
  • Viral Load

Substances

  • Anti-Retroviral Agents
  • HIV Integrase Inhibitors
  • Heterocyclic Compounds, 3-Ring
  • Oxazines
  • Piperazines
  • Pyridones
  • dolutegravir
  • HIV Integrase